Melanoma Institute Australia celebrates International Women's Day
8 March 2017
To celebrate International Women's Day, we're sharing how some of the women who inspire the way we work every day, are showing their commitment to accelerate gender parity.
Meet Danielle Fischer, our Science Communications Specialist.
"I wanted my career to make a difference to people, and I always had a passion for science, so studying Medical Science at uni was the obvious choice. After a few years working in the lab, I decided I enjoyed talking about research rather than actually doing it! And so by accident, I stumbled into Science Communications – a field I never knew existed while studying. It’s the perfect mix for me and I enjoy translating complex medical research for the general public to appreciate. I particularly like translating research that gives hope to patients."
This is Tuba Nur Gide, PhD student and winner of NSW National Council of Women Australia Day Award for her research focused on the role of immunotherapies in melanoma.
"My parents raised me to work hard, be independent and do well academically – they value education very highly. I think that’s why even as a little girl, I knew that I wanted to pursue completing a PhD, in whatever field of study I would end up choosing.
Having been awarded a PhD Scholarship from MIA two years in a row now is an opportunity that I am truly humbled by. Knowing people close to me that have been affected by cancer drives me even further to do the very best that I can.
I believe that it’s really important for females to have equal opportunity. All women should be valued as individuals. We’re strong, we’re smart and no one should push us around. Careers shouldn’t be defined by your gender and I hope that in the future, education opportunities offered to young boys and girls are free of gender bias or sexism.”
Maria Gonzalez, Clinical Trials Manager here at MIA.
"I completed an undergraduate degree in nursing at The University of Sydney and further postgraduate studies in health science. I am fortunate to have accessed training and education which has enabled me to pursue a career combining both cancer care and clinical research.
Women make up about 90% of Australia’s nursing workforce and play a pivotal role in clinical care and research. Today I will be bold and celebrate the valuable contribution and achievements of all nurses in the fight against cancer."
Researchers from MIA will present their latest research findings to the world’s largest oncology conference in early June.
Australian researchers pioneer life-extending treatment for advanced melanoma patients with brain tumours
Australian researchers are the first to demonstrate that patients with advanced melanoma which has spread to the brain can have increased life expectancy and possibly even beat the disease.
Melanoma March 2017 - that's a wrap! Thank you to everyone that helped make it happen.
Thank you so much to all those who contributed in a variety of ways to Melanoma March 2017 in 17 different locations and more around the country! You have contributed to getting the Big Data for Melanoma national Research Project happening!
By looking at the ‘dark matter’ of the genome, new research has found that genetic changes in acral and mucosal melanoma are completely different to mutations found in skin melanoma.
‘Slip, slop, slap’ is synonymous with being Australian and playing it safe in the sun. These sun smart rules reduce our chances of getting melanoma of the skin. However, new research tells a different story for those affected by rarer forms of melanoma.
Using MIA's patient database, researchers have developed conditional survival estimates for Stage III melanoma patients to more accurately predict survival outcomes.
MIA is proud to be celebrating an important milestone – the 60th anniversary of melanoma research and Australian-led global efforts to find a cure.
Research achievements by MIA were celebrated at the annual Sydney Medical School recently.
In this Global Research Report we showcase advances in medical oncology, reveal unexpected pathology in acral and skin melanoma, and uncover biomarkers and new gene targets for melanoma.
Professor’s Long and Scolyer are well known in the academic community and beloved by their patients. But we wanted to get to know our new Conjoint Medical Directors a little more and hear their plans on making an impact on melanoma.
Wyong Rugby League Club Group has joined forces with Melanoma Institute Australia to help end melanoma for future generations.
Melanoma research has reached a milestone with the 10,000th patient giving their permission for their blood and tissue samples to be used in the world’s largest melanoma biospecimen bank.
MIA's researchers and clinicians are in Seattle, USA, today sharing their research findings at the prestigious Society of Surgical Oncology’s Annual Cancer Symposium.
Two of the world’s best minds in melanoma have taken over the academic and clinical leadership of Melanoma Institute Australia (MIA). Professor Georgina Long and Professor Richard Scolyer are the new Conjoint Medical Directors of MIA, and are shaping the future direction of melanoma research, treatment and education.
Meet Georgia, our Clinica Nurse Consultant who provides vital care and education for patients throughout their treatment.
Australia, we need to talk. This week’s dramatic episodes of Married At First Sight have highlighted a tragedy which is ripping Australian families apart. Yet no one is talking about it.
To celebrate International Women's Day 2017, MIA shares how some of the women who inspire the way we work every day, are showing their commitment to accelerate gender parity.
We welcome Mr Grant King to the position of Chairman of the Board of Melanoma Institute Australia, following the retirement of Mr Reg Richardson AM who led the organisation for 10 years.
Congratulations to PhD Student, Tuba Nur Gide who was awarded a NSW National Council of Women Australia Day Award for her PhD research work.